Computational virtual screening and structure-based design of some epidermal growth factor receptor inhibitors

Computational virtual screening and structure-based design of some epidermal growth factor receptor inhibitors

Abstract Background The foremost cause of cancer mortality worldwide was lung cancer. Lung cancer is divided into small cell lung cancer and non-small cell lung cancer (NSCLC). The latter is the main type of lung cancer that account for about 90% of the cancer issues and estimate about 25% of the ca...

Full description

Bibliographic Details
Main Authors:	Muhammad Tukur Ibrahim, Adamu Uzairu, Sani Uba, Gideon Adamu Shallangwa
Format:	Article
Language:	English
Published:	SpringerOpen 2020-08-01
Series:	Future Journal of Pharmaceutical Sciences
Subjects:	Computational Docking EGFRL858R/T790M Inhibitors ADME Drug-likeness
Online Access:	http://link.springer.com/article/10.1186/s43094-020-00074-6

Similar Items

Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidine and thieno[2,3-d]pyrimidine derivatives as novel EGFRL858R/T790M inhibitors
by: Jianfang Fu, et al.
Published: (2023-12-01)

In silico design of EGFRL858R/T790M/C797S inhibitors via 3D-QSAR, molecular docking, ADMET properties and molecular dynamics simulations
by: Hanine Hadni, et al.
Published: (2022-11-01)

Synthesis and initial in vitro evaluation of olmutinib derivatives as prospective imaging probe for non-small cell lung cancer
by: Muammar Fawwaz, et al.
Published: (2024-01-01)

Docking Simulations and Virtual Screening to find Novel Ligands for T3S in Yersinia pseudotuberculosis YPIII, A drug target for type III secretion (T3S) in the Gram-negative pathogen Yersinia pseudotuberculosis
by: Emmanuel Edache, et al.
Published: (2021-05-01)

Coexisting EGFR and TP53 Mutations in Lung Adenocarcinoma Patients Are Associated With COMP and ITGB8 Upregulation and Poor Prognosis
by: Chang Zheng, et al.
Published: (2020-02-01)

Computer-aided design of some quinazoline analogues as epidermal growth factor receptor inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2021-06-01)

Computational modeling of novel quinazoline derivatives as potent epidermal growth factor receptor inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-02-01)

COMPUTATIONAL STUDIES OF SOME BISCOUMARIN AND BISCOUMARIN THIOUREA DERIVATIVES AS ⍺-GLUCOSIDASE INHIBITORS
by: Muhammad Tukur Ibrahim, et al.
Published: (2018-07-01)

A Radiobrominated Tyrosine Kinase Inhibitor for EGFR with L858R/T790M Mutations in Lung Carcinoma
by: Muammar Fawwaz, et al.
Published: (2021-03-01)

Structure-based design and activity modeling of novel epidermal growth factor receptor kinase inhibitors; an in silico approach
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-09-01)

Simultaneous Detection of the T790M and L858R Mutations in the <i>EGFR</i> Gene by Oligoribonucleotide Interference-PCR
by: Keisuke Baba, et al.
Published: (2019-08-01)

Pharmacokinetic predictions and docking studies of substituted aryl amine-based triazolopyrimidine designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH)
by: Zakari Ya’u Ibrahim, et al.
Published: (2021-07-01)

In silico evaluation of some 4-(quinolin-2-yl)pyrimidin-2-amine derivatives as potent V600E-BRAF inhibitors with pharmacokinetics ADMET and drug-likeness predictions
by: Abdullahi Bello Umar, et al.
Published: (2020-09-01)

Profiling the antidepressant properties of phenyl piperidine derivatives as inhibitors of serotonin transporter (SERT) via cheminformatics modeling, molecular docking and ADMET predictions.
by: Sabitu Babatunde Olasupo, et al.
Published: (2020-09-01)

Computational studies of a series of 2-substituted phenyl-2-oxo-, 2-hydroxyl- and 2-acylloxyethylsulfonamides as potent anti-fungal agents
by: Yusuf Isyaku, et al.
Published: (2020-04-01)

Computational evaluation of potent 2-(1H-imidazol-2-yl) pyridine derivatives as potential V600E-BRAF inhibitors
by: Abdullahi Bello Umar, et al.
Published: (2020-11-01)

Quantitative structure-properties relationship and molecular design of some anti-wear lubricant additives
by: Usman Abdulfatai, et al.
Published: (2020-10-01)

Docking-based strategy to design novel flavone-based arylamides as potent V600E-BRAF inhibitors with prediction of their drug-likeness and ADMET properties
by: Abdullahi Bello Umar, et al.
Published: (2020-10-01)

Virtual screening, pharmacokinetics, and molecular dynamics simulations studies to identify potent approved drugs for Chlamydia trachomatis treatment
by: Emmanuel Israel Edache, et al.
Published: (2021-10-01)

Virtual screening of novel pyridine derivatives as effective inhibitors of DNA gyrase (GyrA) of salmonella typhi
by: John Ameji Philip, et al.
Published: (2023-01-01)

Unveiling novel inhibitors of dopamine transporter via in silico drug design, molecular docking, and bioavailability predictions as potential antischizophrenic agents
by: Sabitu Babatunde Olasupo, et al.
Published: (2021-03-01)

Molecular Docking Investigation, Pharmacokinetic Analysis, and Molecular Dynamic Simulation of Some Benzoxaborole-Benzimidazole Hybrids: An Approach to Identifying Superior Onchocerca Inhibitors
by: Fabian Audu Ugbe, et al.
Published: (2023-02-01)

Computational techniques in designing a series of 1,3,4-trisubstituted pyrazoles as unique hepatitis C virus entry inhibitors
by: Stephen Ejeh, et al.
Published: (2021-04-01)

Quantitative structure-activity relationship, molecular docking, drug-likeness, and pharmacokinetic studies of some non-small cell lung cancer therapeutic agents
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-12-01)

Quantitative Structure-Activity Relationship (QSAR) Studies and Molecular docking Simulation of Norepinephrine Transporter (NET) Inhibitors as Anti-psychotic Therapeutic Agents
by: Sabitu Babatunde OLASUPO, et al.
Published: (2020-02-01)

Molecular Docking Screening and Pharmacokinetic Studies of Some Boron-Pleuromutilin Analogues against Possible Targets of Wolbachia pipientis
by: Fabian Audu Ugbe, et al.
Published: (2022-10-01)

In-silico approaches towards the profiling of some anti-dengue virus as potent inhibitors against dengue NS-5 receptor
by: Samuel Ndaghiya Adawara, et al.
Published: (2021-09-01)

Ligand-based drug design and molecular docking simulation studies of some novel anticancer compounds on MALME-3M melanoma cell line
by: Abdullahi Bello Umar, et al.
Published: (2021-01-01)

Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling
by: Sagiru Hamza Abdullahi, et al.
Published: (2023-08-01)

Chemoinformatic studies on some inhibitors of dopamine transporter and the receptor targeting schizophrenia for developing novel antipsychotic agents
by: Sabitu Babatunde Olasupo, et al.
Published: (2020-07-01)

Computer-aided identification of a series of novel ligands showing high potency as hepatitis C virus NS3/4A protease inhibitors
by: Stephen Ejeh, et al.
Published: (2021-01-01)

Quantitative Structure-Properties Relationship of Lubricating Oil Additives and Molecular Dynamic Simulations Studies of Diamond-Like-Carbon (DLC)
by: Usman Abdulfatai, et al.
Published: (2020-08-01)

Ionizing Radiation Reduces TKI Resistance Caused by T790M Mutation in NSCLC Cell Lines
by: Jing LI, et al.
Published: (2015-08-01)

an Asian citrus psyllid parasitoid Tamarixia radiata (Waterston) (Insecta: Hymenoptera: Eulophidae)
by: Rajinder S. Mann, et al.
Published: (2010-07-01)

Virtual screening, pharmacokinetic, and DFT studies of anticancer compounds as potential V600E-BRAF kinase inhibitors
by: Abdullahi B. Umar, PhD, et al.
Published: (2023-10-01)

A combined 2-D and 3-D QSAR modeling, molecular docking study, design, and pharmacokinetic profiling of some arylimidamide-azole hybrids as superior L. donovani inhibitors
by: Fabian Audu Ugbe, et al.
Published: (2022-06-01)

Computational modelling of some anti-friction lubricant additives
by: Usman Abdulfatai, et al.
Published: (2020-04-01)

Computational modeling, ligand-based drug design, drug-likeness and ADMET properties studies of series of chromen-2-ones analogues as anti-cancer agents
by: Sagiru Hamza Abdullahi, et al.
Published: (2022-06-01)

In silico design and pharmacokinetics investigation of some novel hepatitis C virus NS5B inhibitors: pharmacoinformatics approach
by: Stephen Ejeh, et al.
Published: (2022-04-01)

Theoretical activity prediction, structure-based design, molecular docking and pharmacokinetic studies of some maleimides against Leishmania donovani for the treatment of leishmaniasis
by: Fabian Audu Ugbe, et al.
Published: (2022-04-01)